Life sciences company VolitionRx has introduced epigenetic immunoassays, designed for identifying and measuring nucleosome structures in cell culture, serum, plasma or other biofluids. Designed for research use, the NuQ immunoassay ...
Tags: VolitionRx, epigenetic immunoassays, clinical technology